BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30338796)

  • 1. MicroRNA-200a promotes proliferation and invasion of ovarian cancer cells by targeting PTEN.
    Jiang JH; Lv QY; Yi YX; Liao J; Wang XW; Zhang W
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6260-6267. PubMed ID: 30338796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-200a promotes cell invasion and migration of ovarian carcinoma by targeting PTEN.
    Suo HB; Zhang KC; Zhao J
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4080-4089. PubMed ID: 30024595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-19a promotes proliferative and migratory abilities of NSCLC cells by inhibiting PTEN expression.
    Shi J; Han Y; Lin D; Wang K; Liu B; Gao C
    J BUON; 2019; 24(3):955-962. PubMed ID: 31424647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
    Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.
    Li DP; Chai W; Liu YH; Xu TT; Huang H
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3806-3812. PubMed ID: 31115007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q; Guo R; Lin M; Zhou B; Wang Y
    Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-374b accelerates the development of lung cancer through downregulating PTEN expression via activating PI3K/Akt pathway.
    Li J; Zhou Z; Xu FC; Li J; Zeng D; Cao XQ; Han Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1116-1124. PubMed ID: 30779080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of microRNA-21 inhibits trophoblast cell infiltration through targeting PTEN.
    Lou CX; Zhou XT; Tian QC; Xie HQ; Zhang JY
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6181-6189. PubMed ID: 30338782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
    Zhao YL; Huang YM
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-221 promotes myocardial apoptosis caused by myocardial ischemia-reperfusion by down-regulating PTEN.
    Kong QR; Ji DM; Li FR; Sun HY; Wang QX
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3967-3975. PubMed ID: 31115025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H; Zhang Z; Qing X; French SW; Liu D
    Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1.
    Liang TC; Fu WG; Zhong YS
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9988-9995. PubMed ID: 31799668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-200a overexpression in advanced ovarian carcinomas as a prognostic indicator.
    Zhu CL; Gao GS
    Asian Pac J Cancer Prev; 2014; 15(20):8595-601. PubMed ID: 25374174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-200a acts as an oncogene in colorectal carcinoma by targeting PTEN.
    Li Y; Sun J; Cai Y; Jiang Y; Wang X; Huang X; Yin Y; Li H
    Exp Mol Pathol; 2016 Dec; 101(3):308-313. PubMed ID: 27983967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-21 regulates the proliferation and apoptosis of ovarian cancer cells through PTEN/PI3K/AKT.
    Liu HY; Zhang YY; Zhu BL; Feng FZ; Yan H; Zhang HY; Zhou B
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4149-4155. PubMed ID: 31173285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA PCAT6 promotes occurrence and development of ovarian cancer by inhibiting PTEN.
    Kong FR; Lv YH; Yao HM; Zhang HY; Zhou Y; Liu SE
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8230-8238. PubMed ID: 31646553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.
    Zhang BG; Li JF; Yu BQ; Zhu ZG; Liu BY; Yan M
    Oncol Rep; 2012 Apr; 27(4):1019-26. PubMed ID: 22267008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1.
    Gong YB; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.